These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17402684)

  • 1. [Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros].
    Silai R; Moussa M; Abdalli Mari M; Astafieva-Djaza M; Hafidhou M; Oumadi A; Randrianarivelojosia M; Said Ankili A; Said Ahmed B; Gayibor AH; Ariey F; Ringwald P
    Bull Soc Pathol Exot; 2007 Feb; 100(1):6-9. PubMed ID: 17402684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014.
    Paczkowski M; Mwandama D; Marthey D; Luka M; Makuta G; Sande J; Ali D; Troell P; Mathanga DP; Gutman J
    Malar J; 2016 Apr; 15():236. PubMed ID: 27113085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline in vivo, ex vivo and molecular responses of Plasmodium falciparum to artemether and lumefantrine in three endemic zones for malaria in Colombia.
    Aponte S; Guerra ÁP; Álvarez-Larrotta C; Bernal SD; Restrepo C; González C; Yasnot MF; Knudson-Ospina A
    Trans R Soc Trop Med Hyg; 2017 Feb; 111(2):71-80. PubMed ID: 28460112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.
    Meremikwu M; Alaribe A; Ejemot R; Oyo-Ita A; Ekenjoku J; Nwachukwu C; Ordu D; Ezedinachi E
    Malar J; 2006 May; 5():43. PubMed ID: 16704735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series.
    Sondén K; Wyss K; Jovel I; Vieira da Silva A; Pohanka A; Asghar M; Homann MV; Gustafsson LL; Hellgren U; Färnert A
    Clin Infect Dis; 2017 Jan; 64(2):199-206. PubMed ID: 27986683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa.
    Barnes KI; Durrheim DN; Little F; Jackson A; Mehta U; Allen E; Dlamini SS; Tsoka J; Bredenkamp B; Mthembu DJ; White NJ; Sharp BL
    PLoS Med; 2005 Nov; 2(11):e330. PubMed ID: 16187798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia.
    Chanda P; Hawela M; Kango M; Sipilanyambe N
    Malar J; 2006 Aug; 5():75. PubMed ID: 16938133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study.
    Ebstie YA; Zeynudin A; Belachew T; Desalegn Z; Suleman S
    Malar J; 2015 Jun; 14():236. PubMed ID: 26045199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola.
    Kiaco K; Teixeira J; Machado M; do Rosário V; Lopes D
    Malar J; 2015 Dec; 14():504. PubMed ID: 26670642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
    Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
    Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique.
    Thomsen TT; Madsen LB; Hansson HH; Tomás EV; Charlwood D; Bygbjerg IC; Alifrangis M
    Am J Trop Med Hyg; 2013 Mar; 88(3):536-41. PubMed ID: 23382159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K13-Propeller Polymorphisms in Plasmodium falciparum Isolates from Patients in Mayotte in 2013 and 2014.
    Torrentino-Madamet M; Collet L; Lepère JF; Benoit N; Amalvict R; Ménard D; Pradines B
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7878-81. PubMed ID: 26416865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
    Hatz C; Abdulla S; Mull R; Schellenberg D; Gathmann I; Kibatala P; Beck HP; Tanner M; Royce C
    Trop Med Int Health; 1998 Jun; 3(6):498-504. PubMed ID: 9657513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of artemether-lumefantrine treatment in patients with acute uncomplicated Falciparum malaria in Mayotte, a French collectivity of the Comoros Archipelago.
    Tall A; Raharimalala LA; Lepere JF; Receveur MC; Baur F; Rabarijaona LP; Randrianarivelojosia M; Macarry A; Roussin C; Roussin JM; Robert V; Ariey F
    Parasite; 2004 Sep; 11(3):325-8. PubMed ID: 15490758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.